The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAngus Energy Regulatory News (ANGS)

Share Price Information for Angus Energy (ANGS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.425
Bid: 0.40
Ask: 0.45
Change: 0.00 (0.00%)
Spread: 0.05 (12.50%)
Open: 0.425
High: 0.425
Low: 0.425
Prev. Close: 0.425
ANGS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of General Meeting

12 Oct 2023 07:00

RNS Number : 8508P
Angus Energy PLC
12 October 2023
 

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.

12 October 2023

 

Angus Energy Plc

("Angus Energy", the "Company" or together with its subsidiaries, the "Group")

(AIM:ANGS)

 

 

Notice of General Meeting ("GM")

 

The Company announces that is has today posted a Circular to Shareholders convening a General Meeting ("GM") to be held at the offices of Fladgate LLP, 16 Great Queen Street, London WC2B 5DG on Monday 30 October 2023 at 11.00 a.m (the "Circular"). A copy of the Circular is also available from the Company's website, www.angusenergy.co.uk.

 

Extracts from the Circular are set out below including the background:

 

General Meeting

 

On 28 September 2023, the Company announced that Kemexon Ltd has agreed to convert its £3 million Junior Bridge Facility (Kemexon Facility), together with £311,378.19 of interest and £94,441.64 of fees, into equity in the Company at a price of 0.66 pence per share, which would result in the issue of 516,033,308 new Ordinary Shares in the Company (Kemexon Conversion Shares). As explained in that announcement, the Company is required to increase its Directors' authorities to enable it to issue and allot the Kemexon Conversion Shares. Application will be made to the London Stock Exchange for admission of the Kemexon Conversion Shares following the holding of the general meeting to increase the Directors' authorities, and it is expected that admission will become effective and dealings in the Kemexon Conversion Shares on AIM will commence within seven days of the holding and passing of the necessary resolutions.

In addition, the Company is required to increase its Directors' authorities to enable it to allot new Ordinary Shares in connection with the following:

1. the grant to Aleph Finance Limited of warrants to subscribe for up to 300,000,000 new Ordinary Shares (Aleph Warrant Shares) as part of the £6m Junior Bridge Facility arrangements, as announced on 21 July 2023 (Aleph Facility); and

2. in accordance with the terms of the Aleph Facility, the allotment of shares in connection with any future agreement between the Company and Aleph regarding the repayment of the Aleph Facility in equity on maturity in lieu of cash, in either case up to a maximum of 1,500,000,000 new Ordinary Shares (Aleph Facility Shares).

 

In respect of point 2 above, it is a requirement of the Aleph Facility that the Company seek Shareholder approval for the necessary authority to issue such number of Ordinary Shares to be issued regarding mutual agreement to repay the Aleph Facility and therefore whilst the Company does not currently expect these Ordinary Shares to be issued given the ongoing discussions to complete a global refinance of this and other Company indebtedness, it is complying with these requirements now in putting such resolutions to Shareholders. 

Accordingly, the Company is now convening a general meeting (GM) to table the necessary shareholder resolutions to enable the Directors to allot new Ordinary Shares in accordance with the above, being:

1. resolutions to authorise the issue of new Ordinary Shares comprising the Kemexon Conversion Shares, the Aleph Warrant Shares and the Aleph Facility Shares, and to disapply statutory pre-emption rights in respect of such allotments; and

 

2. to authorise the Directors to allot further Ordinary Shares and to disapply statutory pre-emption rights in respect of allotment up to a certain amount. This will give the Directors flexibility to allot further Ordinary Shares in the future should they consider it to be in the best interests of the Company to do so.

 

END

 

For further information on the Company, please visit www.angusenergy.co.uk or contact:

Enquiries:

 

Angus Energy Plc www.angusenergy.co.uk

 

Richard Herbert Tel: +44 (0) 208 899 6380

Beaumont Cornish Limited (Nomad) www.beaumontcornish.com

 

James Biddle / Roland Cornish Tel: +44 (0) 207 628 3396

WH Ireland Limited (Broker)

 

Katy Mitchell / Harry Ansell Tel: +44 (0) 207 220 1666

Flagstaff PR/IR angus@flagstaffcomms.com

 

Tim Thompson / Fergus Mellon Tel: +44 (0) 207 129 1474

 

Aleph Commodities info@alephcommodities.com

 

Disclaimers - this Announcement includes statements that are, or may be deemed to be, "forward-looking statements". These forward-looking statements can be identified by the use of forward-looking terminology, including the terms "believes", "estimates", "forecasts", "plans", "prepares", "anticipates", "projects", "expects", "intends", "may", "will", "seeks", "should" or, in each case, their negative or other variations or comparable terminology, or by discussions of strategy, plans, objectives, goals, future events or intentions. These forward-looking statements include all matters that are not historical facts. They appear in a number of places throughout this Announcement and include statements regarding the Company's and the Directors' intentions, beliefs or current expectations concerning, amongst other things, the Company's prospects, growth and strategy. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. Forward-looking statements are not guarantees of future performance. The Company's actual performance, achievements and financial condition may differ materially from those expressed or implied by the forward-looking statements in this Announcement. In addition, even if the Company's results of operations, performance, achievements and financial condition are consistent with the forward-looking statements in this Announcement, those results or developments may not be indicative of results or developments in subsequent periods. Any forward-looking statements that the Company makes in this Announcement speak only as of the date of such statement and (other than in accordance with their legal or regulatory obligations) neither the Company, nor the Bookrunner nor Beaumont Cornish nor any of their respective associates, directors, officers or advisers shall be obliged to update such statements. Comparisons of results for current and any prior periods are not intended to express any future trends or indications of future performance, unless expressed as such, and should only be viewed as historical data.

Beaumont Cornish Limited, which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is acting as nominated adviser to the Company in relation to the matters referred herein. Beaumont Cornish Limited is acting exclusively for the Company and for no one else in relation to the matters described in this announcement and is not advising any other person and accordingly will not be responsible to anyone other than the Company for providing the protections afforded to clients of Beaumont Cornish Limited, or for providing advice in relation to the contents of this announcement or any matter referred to in it.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NOGFFWFUFEDSEFS
Date   Source Headline
20th Oct 20213:29 pmRNSExtension of Convertible Loan Note Maturity Date
18th Oct 20212:05 pmRNSSecond Price Monitoring Extn
18th Oct 20212:00 pmRNSPrice Monitoring Extension
5th Oct 20214:40 pmRNSSecond Price Monitoring Extn
5th Oct 20214:35 pmRNSPrice Monitoring Extension
24th Sep 20212:50 pmRNSRe-evaluation of Lidsey Field (PL 241)
10th Sep 20219:55 amRNSInvestor Call
16th Aug 20211:22 pmRNSDirector/PDMR Shareholding
11th Aug 20212:30 pmRNSUpdate on Saltfleetby Gas Field
2nd Aug 20217:00 amRNSGeneral Operations Update
26th Jul 20213:30 pmRNSSaltfleetby Planning Update
22nd Jul 20214:01 pmRNSDirector/PDMR Shareholding
15th Jul 20215:14 pmRNSHolding(s) in Company
2nd Jul 20212:06 pmRNSSecond Price Monitoring Extn
2nd Jul 20212:00 pmRNSPrice Monitoring Extension
1st Jul 20217:00 amRNSTotal Voting Rights
29th Jun 20213:44 pmRNSHalf-year Report
18th Jun 20217:00 amRNSAngus presentation at the Proactive One2One Forum
15th Jun 20217:00 amRNSAngus to present at the Proactive One2One Forum
15th Jun 20217:00 amRNSAlignment of Brockham and Lidsey Licence holdings
9th Jun 20214:29 pmRNSApproval of Saltfleetby Field Development Plan
3rd Jun 20217:00 amRNSSaltfleetby Field Finance and Operations Update
13th May 20217:00 amRNSSaltfleetby Finance Facility Signed
9th Apr 202112:43 pmRNSHolding(s) in Company
8th Apr 202110:48 amRNSHolding(s) in Company
1st Apr 20217:00 amRNSIssue of Equity and TVR
31st Mar 20213:37 pmRNSResult of AGM
29th Mar 20217:00 amRNSUpdate re. Saltfleetby Finance Facility
15th Mar 202110:17 amRNSHolding(s) in Company
9th Mar 20217:00 amRNSFinal Results
4th Mar 20217:00 amRNSInvestor Presentation
2nd Mar 20212:05 pmRNSBalcombe Oil Field- Planning Update
24th Feb 202112:00 pmRNSShareholder Update Presentation
22nd Feb 202112:03 pmRNSRe-evaluation of Lidsey Field & Update
22nd Feb 20218:30 amRNSSaltfleetby Loan Facility Update
22nd Feb 20217:00 amRNSBalcombe Field–Planning Recommendation and Meeting
4th Feb 20215:54 pmRNSIssue of Options
4th Feb 20211:52 pmRNSHolding(s) in Company
1st Feb 20213:59 pmRNSFurther Equity Placing
27th Jan 20212:06 pmRNSSecond Price Monitoring Extn
27th Jan 20212:00 pmRNSPrice Monitoring Extension
27th Jan 202112:24 pmRNSEquity Placing
27th Jan 202111:00 amRNSPrice Monitoring Extension
26th Jan 20218:44 amRNSHolding(s) in Company
25th Jan 202110:30 amRNSHolding(s) in Company
25th Jan 20217:00 amRNSSaltfleetby & Debt Funding Update
22nd Jan 20214:41 pmRNSSecond Price Monitoring Extn
22nd Jan 20214:35 pmRNSPrice Monitoring Extension
6th Jan 202112:38 pmRNSHolding(s) in Company
5th Jan 20212:36 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.